CoChat

Complexity of antibiotic resistance and its impact on gut microbiota dynamics

Shayista, H., Prasad, M.N. Nagendra, Raj, S. Niranjan, Prasad, Ashwini, Lakshmi, S., Ranjini, H.K., Manju, K., Ravikumara, Chouhan, Raghuraj Singh, Khohlova, Olga Y., Perianova, Olga V., Baker, Syed · 2025 · Engineering Microbiology
Cited by 47

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

The present review explores the influence of the gut microbiota on antibiotic resistance dynamics, particularly those associated with dysbiosis. The improper use of antibiotics can induce resistance in pathogens through various pathways, which is a topic of increasing interest within the scientific community. This review highlights the importance of microbial diversity, gut metabolism, and inflammatory responses against the dysbiosis due to the action of antibiotics. Additionally, it examines how secondary metabolites secreted by pathogens can serve as biomarkers for the early detection of antibiotic resistance. Although significant progress has been made in this field, key research gaps persist, including the need for a deeper understanding of the long-term effects of antibiotic-induced dysbiosis and the specific mechanisms driving the evolution of resistance in gut bacteria. Based on these considerations, this review systematically analyzed studies from PubMed, Web of Science, Embase, Cochrane Library, and Scopus up to July 2024. This study aimed to explore the dynamics of the interactions between gut microbiota and antibiotic resistance, specifically examining how microbial composition influences the development of resistance mechanisms. By elucidating these relationships, this review provides insights into management strategies for drug resistance and improves our understanding of microbial contributions to host health.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.engmic.2024.100187

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 115

  1. Hugon, 2017, Repertoire of human gut microbes, Microb. Pathog., 106, 103, 10.1016/j.micpath.2016.06.020 · DOI · Paper page
  2. Flint, 2012, Microbial degradation of complex carbohydrates in the gut, Gut. Microbes., 3, 289, 10.4161/gmic.19897 · DOI · Paper page
  3. den Besten, 2013, The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism, J. Lipid Res., 54, 2325, 10.1194/jlr.R036012 · DOI · Paper page
  4. Mondot, 2013, The human gut microbiota and its dysfunctions, Digest. Dis., 31, 278, 10.1159/000354678 · DOI
  5. Sirisinha, 2016, The potential impact of gut on your health: Current status and future challenges, Asian Pac. J. Allergy Immunol.
  6. A. Muthaiyan, Determinants of the gut microbiota, gut microbiota and its impact on health and diseases. (2020) 19–62. 10.1007/978-3-030-47384-6_2. · DOI
  7. Arumugam, 2011, Enterotypes of the human gut microbiota, Nat., 473, 174, 10.1038/nature09944 · DOI · Paper page
  8. Shanahan, 2002, The host–microbe interface within the gut, Best Pract. Res. Clin. Gastroenterol., 16, 915, 10.1053/bega.2002.0342 · DOI · Paper page
  9. S.A. Nasseri, A.C. Lazarski, I.L. Lemmer, C.Y. Zhang, E. Brencher, H.-M. Chen, et al., Functional metagenomics reveals an alternative, broad-specificity pathway for metabolism of carbohydrates in human gut commensal bacteria. (2024). 10.1101/2024.03.25.586180. · doi:10.1101/2024.03.25.586180
  10. Sommer, 2017, The resilience of the intestinal microbiota influences health and disease, Nat. Rev. Microbiol., 15, 630, 10.1038/nrmicro.2017.58 · DOI · Paper page
  11. Janeckova, 2019, Unique gene expression signatures in the intestinal mucosa and organoids derived from germ-free and monoassociated mice, Int. J. Mol. Sci., 20, 1581, 10.3390/ijms20071581 · DOI
  12. Krych, 2013, Quantitatively different, yet qualitatively alike: A meta-analysis of the mouse core gut microbiota with a view towards the human gut microbiota, PLoS. One, 8, 10.1371/journal.pone.0062578 · DOI · Paper page
  13. Lawley, 2013, Intestinal colonization resistance, Immunol., 138, 1, 10.1111/j.1365-2567.2012.03616.x · DOI · Paper page
  14. Salam, 2023, Antimicrobial resistance: a growing serious threat for global public health, Healthcare, 11, 1946, 10.3390/healthcare11131946 · DOI · Paper page
  15. Hansson, 2022, Imagining a post-antibiotic era: A cultural analysis of crisis and antibiotic resistance, Med. Humanit., 48, 381, 10.1136/medhum-2022-012409 · doi:10.1136/medhum-2022-012409
  16. Chinemerem Nwobodo, 2022, Antibiotic resistance: The challenges and some emerging strategies for tackling a Global Menace, J. Clin. Lab. Anal., 36, 10.1002/jcla.24655 · DOI · Paper page
  17. Ahmed, 2024, Antimicrobial resistance: Impacts, challenges, and future prospects, J. Med. Surg. Public Health, 2, 10.1016/j.glmedi.2024.100081 · DOI · Paper page
  18. Raouf, 1992, Extended-spectrum beta-lactamases among Klebsiella pneumoniae from Iraqi patients with community-acquired pneumonia, Rev. Assoc. Med. Bras., 68, 833
  19. Saki, 2022, Beta-lactamase determinants and molecular typing of carbapenem-resistant classic and hypervirulent Klebsiella pneumoniae clinical isolates from southwest of Iran, Front. Microbiol., 13, 10.3389/fmicb.2022.1029686 · DOI
  20. Saki, 2022, Occurrence of plasmid-mediated quinolone resistance genes in Pseudomonas aeruginosa strains isolated from clinical specimens in southwest Iran: a multicentral study, Sci. Rep., 12, 1
  21. Farajzadeh Sheikh, 2020, Emergence of multidrug-resistant Shigella species harboring extended-spectrum beta-lactamase genes in pediatric patients with diarrhea from southwest of Iran, Mol. Biol. Rep., 47, 7097, 10.1007/s11033-020-05776-x · doi:10.1007/s11033-020-05776-x
  22. Garbacz, 2021, Distribution and antibiotic-resistance of different Staphylococcus species identified by matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) isolated from the oral cavity, J. Oral Microbiol., 13, 10.1080/20002297.2021.1983322 · DOI
  23. Yalew, 2022, Prevalence of bacterial vaginosis and aerobic vaginitis and their associated risk factors among pregnant women from northern Ethiopia: A cross-sectional study, PLoS One, 17, 10.1371/journal.pone.0262692 · DOI
  24. Levy, 1982, Microbial resistance to antibiotics, Lancet, 320, 83, 10.1016/S0140-6736(82)91701-9 · DOI · Paper page
  25. Zhao, 2023, Drug-microbiota interactions: an emerging priority for precision medicine, Signal. Transduct. Target. Ther., 8, 1
  26. Xu, 2020, The effect of antibiotics on the gut microbiota: a metagenomics analysis of microbial shift and gut antibiotic resistance in antibiotic treated mice, BMC Genomics, 21, 10.1186/s12864-020-6665-2 · DOI
  27. Francino, 2016, Antibiotics and the human gut microbiota: dysbioses and accumulation of resistances, Front. Microbiol., 6, 10.3389/fmicb.2015.01543 · DOI · Paper page
  28. Pérez-Cobas, 2012, Gut microbiota disturbance during antibiotic therapy: A multi-omic approach, Gut, 62, 1591, 10.1136/gutjnl-2012-303184 · DOI · Paper page
  29. Raplee, 2021, Emergence of nosocomial associated opportunistic pathogens in the gut microbiota after antibiotic treatment, Antimicrob. Resist. Infect. Control, 10, 10.1186/s13756-021-00903-0 · DOI
  30. Zhang, 2021, Antibiotic-induced gut microbiota dysbiosis damages the intestinal barrier, increasing food allergy in adult mice, Nutrients, 13, 3315, 10.3390/nu13103315 · DOI
  31. Dahiya, 2023, Antibiotic-therapy-induced gut dysbiosis affecting gut microbiota—brain axis and cognition: Restoration by intake of probiotics and Synbiotics, Int. J. Mol. Sci., 24, 3074, 10.3390/ijms24043074 · DOI · Paper page
  32. Garneau-Tsodikova, 2016, Mechanisms of resistance to aminoglycoside antibiotics: Overview and perspectives, Medchemcomm, 7, 11, 10.1039/C5MD00344J · DOI · Paper page
  33. Pradier, 2023, Ecology, more than antibiotics consumption, is the major predictor for the global distribution of aminoglycoside-modifying enzymes, Elife, 12
  34. Shao, 2020, Gut microbiota characteristics in mice with antibiotic-associated diarrhea, BMC Microbiol., 20, 10.1186/s12866-020-01999-x · DOI
  35. Sparo, 2018, Impact on public health of the spread of high-level resistance to gentamicin and vancomycin in enterococci, Front. Microbiol., 9, 10.3389/fmicb.2018.03073 · DOI
  36. Tang, 2014, Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria, Adv. Drug Deliv. Rev., 78, 3, 10.1016/j.addr.2014.08.003 · DOI · Paper page
  37. Lima, 2020, β-lactam antibiotics: An overview from a medicinal chemistry perspective, Eur. J. Med. Chem., 208, 10.1016/j.ejmech.2020.112829 · DOI · Paper page
  38. Davies, 2021, Designing inhibitors of β-lactamase enzymes to overcome carbapenem resistance in gram-negative bacteria, Acc. Chem. Res., 54, 2055, 10.1021/acs.accounts.0c00863 · DOI
  39. Zapun, 2008, Penicillin-binding proteins and β-lactam resistance, FEMS Microbiol. Rev., 32, 361, 10.1111/j.1574-6976.2007.00095.x · DOI · Paper page
  40. Lu, 2020, Effects of β-lactam antibiotics on gut microbiota colonization and metabolites in late preterm infants, Curr. Microbiol., 77, 3888, 10.1007/s00284-020-02198-7 · DOI
  41. Liu, 2020, Amoxicillin increased functional pathway genes and beta-lactam resistance genes by pathogens bloomed in intestinal microbiota using a simulator of the human intestinal microbial ecosystem, Front. Microbiol., 11
  42. Livanos, 2016, Antibiotic-mediated gut microbiota perturbation accelerates development of type 1 diabetes in mice, Nat. Microbiol., 1, 10.1038/nmicrobiol.2016.140 · DOI · Paper page
  43. de Lastours, 2015, Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance, Future Microbiol., 10, 1241, 10.2217/fmb.15.40 · DOI
  44. Jeong, 2009, Risk assessment of ciprofloxacin, flavomycin, olaquindox and colistin sulfate based on microbiological impact on human gut biota, Regul. Toxicol. Pharmacol., 53, 209, 10.1016/j.yrtph.2009.01.004 · DOI
  45. Brar, 2020, Fluoroquinolone antibiotics: An overview, Adesh Univ. J. Med. Sci. Res., 2, 26
  46. Park, 2014, Ciprofloxacin usage and bacterial resistance patterns in Crohn's disease patients with abscesses, J. Clin. Gastroenterol., 48, 703, 10.1097/MCG.0000000000000024 · DOI
  47. Zhu, 2020, Assessment of oral ciprofloxacin impaired gut barrier integrity on gut bacteria in mice, Int. Immunopharmacol., 83, 10.1016/j.intimp.2020.106460 · DOI
  48. Edlund, 2000, Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora, Scand. J. Infect. Dis., 32, 81, 10.1080/00365540050164272 · DOI
  49. Vázquez-Laslop, 2018, How macrolide antibiotics work, Trends. Biochem. Sci., 43, 668, 10.1016/j.tibs.2018.06.011 · DOI · Paper page
  50. Nakajima, 1999, Mechanisms of bacterial resistance to macrolide antibiotics, J. Infect. Chemotherapy, 5, 61, 10.1007/s101560050011 · DOI
  51. Pickering, 2022, Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiota in children: A randomized, controlled trial, Gut. Pathog., 14, 10.1186/s13099-021-00478-6 · DOI
  52. Milanović, 2019, Erythromycin-resistant lactic acid bacteria in the healthy gut of vegans, ovo-lacto vegetarians and omnivores, PLoS One, 14, 10.1371/journal.pone.0220549 · DOI
  53. Lathakumari, 2024, Antibiotics and the gut microbiota: Understanding the impact on human health, Med. Microecol., 20, 10.1016/j.medmic.2024.100106 · DOI
  54. Chopyk, 2023, Common antibiotics, azithromycin and amoxicillin, affect gut metagenomics within a household, BMC Microbiol., 23, 10.1186/s12866-023-02949-z · DOI
  55. Choo, 2023, The impact of long-term macrolide exposure on the gut microbiota and its implications for metabolic control, Microbiol. Spectr., 11, 10.1128/spectrum.00831-23 · DOI
  56. Jaroszewski, 2023, Bidirectional interaction between tetracyclines and gut microbiome, Antibiotics, 12, 1438, 10.3390/antibiotics12091438 · DOI
  57. Speer, 1992, Bacterial resistance to tetracycline: Mechanisms, transfer, and clinical significance, Clin. Microbiol. Rev., 5, 387, 10.1128/CMR.5.4.387 · DOI · Paper page
  58. de Cristobal, 2006, Multidrug resistance pump acrAB-tolC is required for high-level, tet(A)-mediated tetracycline resistance in Escherichia coli, J. Antimicrobial Chemotherapy, 58, 31, 10.1093/jac/dkl172 · DOI
  59. Beheshti, 2020, Tetracycline resistance mediated by Tet efflux pumps in clinical isolates of Acinetobacter baumannii, Rev. Do Instituto Medicina Tropical São Paulo, 62
  60. Levy, 2002, Active efflux, a common mechanism for biocide and antibiotic resistance, J. Appl. Microbiol., 92, 10.1046/j.1365-2672.92.5s1.4.x · DOI · Paper page
  61. Aires, 2007, Tetracycline resistance mediated by tet (W), tet (M), and tet (O) genes of Bifidobacterium isolates from humans, Appl. Environ. Microbiol., 73, 2751, 10.1128/AEM.02459-06 · DOI
  62. Yang, 2004, TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics, J. Biol. Chem., 279, 52346, 10.1074/jbc.M409573200 · DOI · Paper page
  63. Akinbowale, 2007, Diversity of tetracycline resistance genes in bacteria from aquaculture sources in Australia, J. Appl. Microbiol., 103, 2016, 10.1111/j.1365-2672.2007.03445.x · DOI · Paper page
  64. de Vries, 2011, The gut as reservoir of antibiotic resistance: Microbial diversity of tetracycline resistance in mother and infant, PLoS. One, 6, 10.1371/journal.pone.0021644 · DOI · Paper page
  65. Granados-Chinchilla, 2017, Tetracyclines in food and feedingstuffs: From regulation to analytical methods, bacterial resistance, and environmental and Health Implications, J. Anal. Methods Chem., 1, 10.1155/2017/1315497 · DOI · Paper page
  66. Jetty, 2023, Emergence of third generation tetracyclines: New magic bullets to tackle antibiotic resistance in the post-antibiotic era, Asian J. Res. Infect. Dis., 13, 1, 10.9734/ajrid/2023/v13i4271 · DOI
  67. Karami, 2006, Tetracycline resistance in Escherichia coli and persistence in the infantile colonic microbiota, Antimicrob. Agents Chemother, 50, 156, 10.1128/AAC.50.1.156-161.2006 · DOI
  68. Yin, 2015, Metagenomic insights into tetracycline effects on microbial community and antibiotic resistance of Mouse Gut, Ecotoxicology, 24, 2125, 10.1007/s10646-015-1540-7 · DOI
  69. Jostins, 2012, Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, 491, 119, 10.1038/nature11582 · DOI · Paper page
  70. Swer, 2022, Gut microbiota-derived metabolites and their importance in neurological disorders, Mol. Biol. Rep., 50, 1663, 10.1007/s11033-022-08038-0 · DOI
  71. Li, 2018, Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells, Eur. J. Pharmacol., 831, 52, 10.1016/j.ejphar.2018.05.003 · DOI · Paper page
  72. Farup, 2016, Faecal short-chain fatty acids - A diagnostic biomarker for irritable bowel syndrome?, BMC Gastroenterol., 16, 10.1186/s12876-016-0446-z · DOI · Paper page
  73. Mortensen, 1996, Short-chain fatty acids in the human colon: Relation to gastrointestinal health and disease, Scand. J. Gastroenterol., 31, 132, 10.3109/00365529609094568 · DOI · Paper page
  74. Niccolai, 2019, Evaluation and comparison of short chain fatty acids composition in gut diseases, World J. Gastroenterol., 25, 5543, 10.3748/wjg.v25.i36.5543 · DOI
  75. Praveenraj, 2022, The role of a gut microbial-derived metabolite, trimethylamine N-oxide (TMAO), in neurological disorders, Mol. Neurobiol., 59, 6684, 10.1007/s12035-022-02990-5 · DOI
  76. Mutengo, 2023, Gut microbiota dependant trimethylamine N-oxide and hypertension, Front. Physiol., 14, 10.3389/fphys.2023.1075641 · DOI
  77. Livshits, 2019, Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis, Ageing Res. Rev., 56, 10.1016/j.arr.2019.100980 · DOI · Paper page
  78. Chiang, 2013, Bile acid metabolism and signaling, Compr. Physiol., 1191
  79. Larabi, 2023, Bile acids as modulators of gut microbiota composition and function, Gut. Microbes., 15, 10.1080/19490976.2023.2172671 · DOI · Paper page
  80. Andreescu, 2023, Molecular insights into the role of gut microbiota in antibiotic therapy selection and resistance mitigation, Cureus, 15
  81. Joyce, 2017, Disease-associated changes in bile acid profiles and links to altered gut microbiota, Digest. Dis., 35, 169, 10.1159/000450907 · DOI
  82. Tsuei, 2014, Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer, Exp. Biol. Med., 239, 1489, 10.1177/1535370214538743 · DOI · Paper page
  83. Carabotti, 2015, The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems, Ann. Gastroenterol., 28, 203
  84. Bartocci, 2023, Mental illnesses in inflammatory bowel diseases: mens sana in corpore sano, Medicina (Kaunas), 59, 682, 10.3390/medicina59040682 · DOI
  85. Shah, 2021, The intestinal microbiota: Impacts of antibiotics therapy, colonization resistance, and diseases, Int. J. Mol. Sci., 22, 6597, 10.3390/ijms22126597 · DOI · Paper page
  86. Holota, 2019, The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity, PLoS One, 14, 10.1371/journal.pone.0220642 · DOI
  87. Kadry, 2023, Impact of short chain fatty acids (scfas) on antimicrobial activity of new β-lactam/β-lactamase inhibitor combinations and on virulence of escherichia coli isolates, J. Antibiot. (Tokyo), 76, 225, 10.1038/s41429-023-00595-1 · DOI
  88. Gu, 2020, Effect of the short-term use of fluoroquinolone and β-lactam antibiotics on mouse gut microbiota, Infect. Drug Resist., 13, 4547, 10.2147/IDR.S281274 · DOI
  89. Behr, 2017, Gut microbiome-related metabolic changes in plasma of antibiotic-treated rats, Arch. Toxicol., 91, 3439, 10.1007/s00204-017-1949-2 · DOI
  90. Choo, 2023, The impact of long-term macrolide exposure on the gut microbiome and its implications for metabolic control, Microbiol. Spectr., 11, 10.1128/spectrum.00831-23 · DOI
  91. Nowiński, 2018, Trimethylamine N -oxide: A harmful, protective or diagnostic marker in lifestyle diseases?, Nutrition, 46, 7, 10.1016/j.nut.2017.08.001 · DOI
  92. Rüb, 2021, Biomarkers of human gut microbiota diversity and dysbiosis, Biomark. Med., 15, 139, 10.2217/bmm-2020-0353 · DOI
  93. Shayista, 2024, Mechanistic overview of gut microbiota and mucosal pathogens with respect to cardiovascular diseases, Microbiology, 5
  94. Kruger, 2024, Evaluation of inter- and intra-variability in gut health markers in healthy adults using an optimised faecal sampling and processing method, Sci. Rep., 14, 10.1038/s41598-024-75477-z · DOI
  95. Nicholson, 2012, Host-gut microbiota metabolic interactions, Science (1979), 336, 1262
  96. Zhu, 2016, Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk, Cell, 165, 111, 10.1016/j.cell.2016.02.011 · DOI · Paper page
  97. Yadav, 2022, Nanomaterial-based electrochemical Nanodiagnostics for human and gut metabolites diagnostics: Recent advances and challenges, Biosensors, 12, 733, 10.3390/bios12090733 · DOI
  98. Zhang, 2022, Gut microbial metabolite tmao increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patients, Transl. Res., 240, 50, 10.1016/j.trsl.2021.10.001 · DOI
  99. Wang, 2011, Gut Flora Metabolism of phosphatidylcholine promotes cardiovascular disease, Nature, 472, 57, 10.1038/nature09922 · DOI · Paper page
  100. Koh, 2016, From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites, Cell, 165, 1332, 10.1016/j.cell.2016.05.041 · DOI · Paper page
  101. Lerner, 2017, Potential effects of horizontal gene exchange in the human gut, Front. Immunol., 8, 10.3389/fimmu.2017.01630 · DOI · Paper page
  102. Zeng, 2017, Factors influencing horizontal gene transfer in the intestine, Anim. Health Res. Rev., 18, 153, 10.1017/S1466252317000159 · DOI · Paper page
  103. Li, 2020, Understanding horizontal gene transfer network in human gut microbiota, Gut. Pathog., 12, 10.1186/s13099-020-00370-9 · DOI
  104. Hughes, 2017, Evolutionary trajectories to antibiotic resistance, Annu. Rev. Microbiol., 71, 579, 10.1146/annurev-micro-090816-093813 · DOI · Paper page
  105. Chopra, 2003, The role of mutators in the emergence of antibiotic-resistant bacteria, Drug Resist. Updates, 6, 137, 10.1016/S1368-7646(03)00041-4 · DOI · Paper page
  106. Lin, 2020, Contribution of biofilm formation genetic locus, pgaabcd, to antibiotic resistance development in gut microbiota, Gut. Microbes., 12, 10.1080/19490976.2020.1842992 · DOI
  107. Lewis, 2008, Multidrug tolerance of biofilms and Persister cells, Curr. Top. Microbiol. Immunol., 107
  108. Nath, 2020, Prevalence of antibiotic-resistant, toxic metal-tolerant and biofilm-forming bacteria in hospital surroundings, Environ. Anal. Health Toxicol., 35, 10.5620/eaht.2020018 · DOI
  109. Wu, 2021, Metagenomics-based analysis of the age-related cumulative effect of antibiotic resistance genes in gut microbiota, Antibiotics, 10, 1006, 10.3390/antibiotics10081006 · DOI
  110. Wiest, 2005, Bacterial translocation, Biosci. Microflora, 24, 61, 10.12938/bifidus.24.61 · DOI
  111. Wang, 2019, Microbiota-immune interaction in the pathogenesis of gut-derived infection, Front. Immunol., 10
  112. Yu, 2014, Enteric dysbiosis promotes antibiotic-resistant bacterial infection: Systemic dissemination of resistant and commensal bacteria through epithelial transcytosis, Am. J. Physiol.-Gastrointestinal Liver Physiol., 307, 10.1152/ajpgi.00070.2014 · DOI
  113. Wells, 1988, Proposed mechanisms for the translocation of intestinal bacteria, Clin. Infect. Dis., 10, 958, 10.1093/clinids/10.5.958 · DOI · Paper page
  114. Knoop, 2015, Antibiotics promote inflammation through the translocation of native commensal colonic bacteria, Gut, 65, 1100, 10.1136/gutjnl-2014-309059 · DOI · Paper page
  115. Baker, 2023, Efficacy of breast milk components against microbial pathogens to combat drug-resistance, Microbe, 1, 10.1016/j.microb.2023.100010 · DOI

Cited by

See all 47

Metadata

Authors
Shayista, H., Prasad, M. N. N., Raj, S. N., Prasad, A., Lakshmi, S., Ranjini, H. K., Manju, K., Ravikumara, Chouhan, R. S., Khohlova, O. Y., Perianova, O. V., & Baker, S.
Venue
Engineering Microbiology
Publisher
Elsevier BV
Published
2025-03
Volume
5
Issue
1
Pages
100187
ISSN
2667-3703
Cited by
47
References
20
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Complexity of antibiotic resistance and its impact on gut microbiota dynamics. https://app.cochat.ai/papers/10.1016/j.engmic.2024.100187
The paper
Shayista, H., Prasad, M. N. N., Raj, S. N., Prasad, A., Lakshmi, S., Ranjini, H. K., Manju, K., Ravikumara, Chouhan, R. S., Khohlova, O. Y., Perianova, O. V., & Baker, S. (2025). Complexity of antibiotic resistance and its impact on gut microbiota dynamics. Engineering Microbiology. https://doi.org/10.1016/j.engmic.2024.100187

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.